Skripsi
PREVALENSI DAN POLA SENSITIVITAS MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA (MDR-PA) TERHADAP ANTIBIOTIK PADA PASIEN INTENSIVE CARE UNIT (ICU) RSMH PALEMBANG PERIODE JANUARI-DESEMBER 2024
Background: The increasing global prevalence of multidrug-resistant Pseudomonas aeruginosa (MDR-PA) and the emergence of difficult-to-treat resistant P. aeruginosa (DTR-PA) have limited treatment options for patients in intensive care units (ICUs). Local data on the prevalence and resistance patterns of MDR-PA in Palembang ICUs remain limited. Objective: To determine the prevalence, susceptibility pattern, and temporal trends of MDR-PA, carbapenem-resistant P. aeruginosa (CRPA), and DTR-PA, and their distribution by age, sex, and specimen type. Method: A retrospective descriptive study was conducted using ICU patients data at Dr. Mohammad Hoesin Central General Hospital, Palembang, from January–December 2024. Result: MDR-PA isolates had the highest prevalence (14,1%) compared to CRPA MDR, CRPA non-MDR, and assumed-DTR-PA. Amikacin demonstrated the highest susceptibility among all isolates. Conclusion: Amikacin may be considered a potential therapeutic option for infections caused by MDR-PA, CRPA, and assumed-DTR-PA in ICU patients.